Vaccine Production & Bioprocessing
Do you need to eliminate BSE/TSE & mammalian viral risks? Worthington offers Animal Free (AF) nucleases & proteases for vaccine and bioprocessing applications.
Worthington is a privately owned, ISO9001 Certified primary producer of purified enzymes, proteins and nucleic acids for biotech and life science research, regenerative medicine, diagnostic, biopharmaceutical and bioprocessing applications under GMP guidelines.
Products include:
- Two grades of non-mammalian Animal Free (AF) Recombinant DNase I (pdf)
- Aspergillus AF RNase T1 & T2
- Plant & fungal sourced AOF proteases
- NEW Animal Free Collagenase (CLSAFA, AFB, AFC)
- NEW STEMxyme® 1 & 2, Animal Free Collagenase/Neutral Protease Blends
- AF Neutral Protease (Dispase®)
Also, for molecular biology and bioprocessing applications:
- RNase-free DNase (pdf)
- DNase-free RNase (pdf)
- Proteinase K
For classical cell isolation, immunoconjugation, and vaccine production applications:
For proteomics and sequencing, Worthington offers SequENZ® Trypsin, chemically modified for minimal autolysis at neutral pH's along with Sequencing Grades of Chymotrypsin (CDSEQ), Staph Protease/Endo-GLU-C (STSEQ) and Clostripain/Endo-ARG-C (CPSEQ).
As a primary manufacturer, Worthington can meet enzyme requirements from research-scale to bulk bioprocessing quantities.